Biomedical Journal (Aug 2020)
Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan
- Shiu-Feng Huang,
- Yhu-Chering Huang,
- Feng-Yee Chang,
- Jung-Chung Lin,
- Chun-Hsiang Chiu,
- Chien-Wen Chen,
- Fu-Der Wang,
- Yen-Ling Chiu,
- Shu-Hsing Cheng,
- Chien-Yu Cheng,
- Yi-Chun Lin,
- Cheng-Pin Chen,
- Chien-Hsien Huang,
- Po-Yu Liu,
- Yuan-Ti Lee,
- Chen-Hsiang Lee,
- Yao-Shen Chen,
- Cheng-Len Sy,
- Yu-Ting Tseng,
- Cheng-Ting Hsu,
- Chia-Chun Tseng,
- Yu-Lin Lee,
- Chun-Eng Liu,
- Huey-Kang Sytwu
Affiliations
- Shiu-Feng Huang
- Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan; Corresponding author. Institute of Molecular and Genomic Medicine, National Health Research Institutes, 35, Keyan Rd., Zhunan, Miaoli 350, Taiwan.
- Yhu-Chering Huang
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
- Feng-Yee Chang
- Division of Infectious Diseases and Tropical Medicine, Tri-Service General Hospital, Taipei, Taiwan
- Jung-Chung Lin
- Division of Infectious Diseases and Tropical Medicine, Tri-Service General Hospital, Taipei, Taiwan
- Chun-Hsiang Chiu
- Division of Infectious Diseases and Tropical Medicine, Tri-Service General Hospital, Taipei, Taiwan
- Chien-Wen Chen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan
- Fu-Der Wang
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan
- Yen-Ling Chiu
- Division of Nephrology, Core Laboratories, Department of Medical Research, Far Eastern Memorial Hospital, New Taipei, Taiwan
- Shu-Hsing Cheng
- Division of Infectious Disease, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
- Chien-Yu Cheng
- Division of Infectious Disease, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan; School of Public Health, National Yang-Ming University, Taipei, Taiwan
- Yi-Chun Lin
- Division of Infectious Disease, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
- Cheng-Pin Chen
- Division of Infectious Disease, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
- Chien-Hsien Huang
- Division of Infectious Disease, Department of Internal Medicine, Shin Kong Wu Ho Su Memorial Hospital, Taipei, Taiwan
- Po-Yu Liu
- Division of Infectious Disease, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
- Yuan-Ti Lee
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan
- Chen-Hsiang Lee
- Department of Internal Medicine, Chang Gung Memorial Hospital at Kaohsiung, Taiwan
- Yao-Shen Chen
- Section of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- Cheng-Len Sy
- Section of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- Yu-Ting Tseng
- Section of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- Cheng-Ting Hsu
- Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- Chia-Chun Tseng
- Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- Yu-Lin Lee
- Division of Infectious Diseases, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
- Chun-Eng Liu
- Division of Infectious Diseases, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
- Huey-Kang Sytwu
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan
- Journal volume & issue
-
Vol. 43,
no. 4
pp. 314 – 317
Abstract
By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients’ blood samples for Taiwan researchers and industries in an emergent way. It was set up in less than 3 weeks and quickly opened for application. By August 5, 2020, this COVID-19 biobank has collected 165 blood samples of 110 patients from more than 10 hospitals across north, middle and south part of Taiwan, including both COVID-19 (+) and (-) pneumonia patients. This biobank can provide applicants with biosamples, such as serum, DNA and RNA, and also the clinical and genomic data, so as to accelerate the COVID-19 treatment and prevention research in Taiwan. This COID-19 biobank already received 15 applications. It has become the most important research resource for the COVID-19 pandemic in Taiwan, including new screening reagents, disease mechanism, the variable human responses and epidemic preventions. Since it is publicly available for both academic and industrial applicants.
